92
Profiles in the current library
92 profiles with cited evidence and clearly labeled related non-peptide references. The September 30, 2026 review updated selected profiles; individual source dates remain visible.
Peptide education. Private progress.
Understand the evidence. Organize your own records. Bring more context to your next clinician conversation—all in one private iPhone app.
Explore the sample preview before subscribing. No app account required.

Evidence Lens · Go beyond the headline
A claim is only the beginning. Explore how it is supported, follow its sources, and keep the uncertainties in view.
Distinguish animal research, human trials, approved labeling, and safety notices. Counts represent claims—not a score for safety or effectiveness.
Open its attached references and plain-language context. No unrelated sources are substituted.
Research filters keep safety and uncertainty accessible. Evidence type is never a personalized recommendation.
Evidence Lens is available now in 1.1.8. Update Peptide Clarity on the App Store to explore it.

Inside 1.1.8
Revisit saved profiles, compare evidence with its limits in view, and open your daily records from a private Home Screen shortcut. The cited library keeps research and approved uses clearly separated.
92
92 profiles with cited evidence and clearly labeled related non-peptide references. The September 30, 2026 review updated selected profiles; individual source dates remain visible.
400
Updated research summaries and corrected study details keep findings, limitations, and product-specific approved uses clearly separated.
164
Follow the sources behind each claim. Clearer safety notes and age restrictions help you understand the context—not choose a treatment.
Released October 1, 2026. Library review completed September 30, 2026. Research changes over time; review dates and citations help you judge the context. View the App Store listing ↗
The September 30, 2026 editorial update includes 92 profiles, 400 claims and 164 references. Version 1.1.8 is available now on the App Store.
Save library profiles on your device, compare two profiles with source coverage and evidence types, and add the Today Home Screen shortcut without displaying personal health details. Comparisons are educational—not treatment rankings. This release also improves check-in validation, subscription grace-period handling, and support requests.
Editorial dates do not indicate new approval or live checks. This update history begins September 30, 2026. Research summaries remain educational, with study limitations kept in view.
The October 4 library update adds eight evidence summaries and five citations across retatrutide, survodutide, orforglipron, semaglutide, and teriparatide, plus three corrected trial-publication dates. It contains 92 profiles, 408 evidence points, and 169 source records. Study limitations, safety context, and historical review dates remain visible.
This update is not yet available in the App Store. Availability depends on Apple approval and release. The current download and screenshots above describe version 1.1.8.
A look inside
Real screens from version 1.1.8, shown with sample records—not treatment recommendations or promised results. In the app, explore the sample preview before choosing a subscription. Nothing in that preview is saved.

92 curated profiles bring approval status, evidence summaries, safety context, and sources together. Related non-peptide references are clearly labeled.

See your own schedule and record completed or skipped entries. The app does not choose a treatment or dose for you.

Review check-ins and trends, then create a PDF from the records you choose to share with your clinician.
Why full access
Move from cited education to today's personal record and a shareable progress summary. No ads, no separate app account, and no automated treatment recommendations.
Learn
Browse cited profiles with approved uses, investigational findings, safety context, and primary sources kept clearly separated.
Track
Organize the schedule you already follow, record completed or skipped entries, and use reminders that stay discreet by default.
Review
Review check-ins and trends over time, then create a neutral clinician-ready PDF containing only the records you choose.
Simple pricing · Full access
Both plans unlock the complete library, tracking, reminders, progress tools, private iCloud sync, and clinician-ready reports.
$3.99per month
Billed monthly
Flexible full access with the freedom to cancel through Apple at any time.
Get Peptide Clarity$14.99per year
About $1.25 per month
The complete experience for a full year while saving about 69% versus monthly.
Get Peptide ClarityU.S. subscriptions are $3.99 monthly or $14.99 yearly. Apple’s purchase confirmation shows the price and terms that apply to you; localized prices and availability may vary. Eligible new subscribers receive a 3-day free trial.
Subscriptions renew automatically unless canceled through Apple. If access expires, your existing records remain readable, exportable, and deletable; creating and editing records requires active access.
Full access includes
01
Your data
How Peptide Clarity handles private records, iCloud sync, photos, notifications, and exports.
02
Using the app
Educational-use terms, subscription details, medical disclaimer, and acceptable use.
03
Need help?
Get help with purchases, restoring access, iCloud sync, notifications, and using the app.
Important
Peptide Clarity does not diagnose, prescribe, recommend dosing, or replace a licensed healthcare professional. Seek qualified medical advice for personal treatment decisions and urgent care for emergencies.